BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1437 related articles for article (PubMed ID: 24388213)

  • 21. Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII.
    Joseph K; Tholanikunnel BG; Kaplan AP
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):896-900. PubMed ID: 11792853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
    Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
    Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.
    Madsen DE; Sidelmann JJ; Biltoft D; Gram J; Hansen S
    Biochim Biophys Acta; 2015 Jun; 1850(6):1336-42. PubMed ID: 25800206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
    Zeerleder S; Levi M
    Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
    Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
    Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.
    Joseph K; Shibayama Y; Nakazawa Y; Peerschke EI; Ghebrehiwet B; Kaplan AP
    Immunopharmacology; 1999 Sep; 43(2-3):203-10. PubMed ID: 10596854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade.
    Kaplan AP; Joseph K
    Immunol Allergy Clin North Am; 2017 Aug; 37(3):513-525. PubMed ID: 28687106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the plasma kinin forming cascade along cell surfaces.
    Kaplan AP; Joseph K; Shibayama Y; Reddigari S; Ghebrehiwet B
    Int Arch Allergy Immunol; 2001; 124(1-3):339-42. PubMed ID: 11307009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The complex role of kininogens in hereditary angioedema.
    Kaplan AP; Joseph K; Ghebrehiwet B
    Front Allergy; 2022; 3():952753. PubMed ID: 35991308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc-dependent activation of the plasma kinin-forming cascade by aggregated beta amyloid protein.
    Shibayama Y; Joseph K; Nakazawa Y; Ghebreihiwet B; Peerschke EI; Kaplan AP
    Clin Immunol; 1999 Jan; 90(1):89-99. PubMed ID: 9884356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
    Joseph K; Tholanikunnel BG; Wolf B; Bork K; Kaplan AP
    J Allergy Clin Immunol; 2016 Jun; 137(6):1822-1829.e1. PubMed ID: 26395818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of hereditary angioedema.
    Canonica GW; Rossi O
    Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary angioedema in childhood: an approach to management.
    Ebo DG; Verweij MM; De Knop KJ; Hagendorens MM; Bridts CH; De Clerck LS; Stevens WJ
    Paediatr Drugs; 2010 Aug; 12(4):257-68. PubMed ID: 20593909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary angioedema: the plasma contact system out of control.
    De Maat S; Hofman ZLM; Maas C
    J Thromb Haemost; 2018 Sep; 16(9):1674-1685. PubMed ID: 29920929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor.
    Larrauri B; Hester CG; Jiang H; Miletic VD; Malbran A; Bork K; Kaplan A; Frank M
    Mol Immunol; 2021 Aug; 136():150-160. PubMed ID: 34153620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.
    Duckworth EJ; Murugesan N; Li L; Rushbrooke LJ; Lee DK; De Donatis GM; Maetzel A; Yea CM; Hampton SL; Feener EP
    Clin Exp Allergy; 2022 Sep; 52(9):1059-1070. PubMed ID: 35278245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
    Fernando LP; Natesan S; Joseph K; Kaplan AP
    Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinins, airway obstruction, and anaphylaxis.
    Kaplan AP
    Chem Immunol Allergy; 2010; 95():67-84. PubMed ID: 20519882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
    Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
    Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of high molecular weight kininogen binding proteins on endothelial cells.
    Joseph K; Tholanikunnel BG; Ghebrehiwet B; Kaplan AP
    Thromb Haemost; 2004 Jan; 91(1):61-70. PubMed ID: 14691569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.